These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 4206490

  • 1. Childhood acromegaly: successful therapy with conventional radiation and effects of chlorpromazine on growth hormone and prolactin secretion.
    AvRuskin TW, Sau K, Tang S, Juan C.
    J Clin Endocrinol Metab; 1973 Sep; 37(3):380-8. PubMed ID: 4206490
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chlorpromazine treatment and growth hormone secretory responses in acromegaly.
    Dimond RC, Bramer SR, Atkinson RL, Howard WJ, Earll JM.
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1189-95. PubMed ID: 4706207
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inappropriate secretion of thyrotropin: discordance between the suppressive effects of corticosteroids and thyroid hormone.
    Smallridge RC, Wartofsky L, Dimond RC.
    J Clin Endocrinol Metab; 1979 Apr; 48(4):700-5. PubMed ID: 107182
    [No Abstract] [Full Text] [Related]

  • 7. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V, Nedvídková J.
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.
    Faglia G, Beck-Peccoz P, Ferrari C, Travaglini P, Ambrosi B, Spada A.
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1259-62. PubMed ID: 4196265
    [No Abstract] [Full Text] [Related]

  • 10. Regulation of growth hormone and prolactin secretion in patients with acromegaly and-or excessive prolactin secretion.
    Cryer PE, Jacobs LS, Daughaday WH.
    Mt Sinai J Med; 1973 Jun; 40(3):402-13. PubMed ID: 4197309
    [No Abstract] [Full Text] [Related]

  • 11. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J, Límanová Z, Srámková J.
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [Abstract] [Full Text] [Related]

  • 12. Acromegaly treated with chlorpromazine. A case study.
    Kolodny HD, Sherman L, Singh A, Kim S, Benjamin F.
    N Engl J Med; 1971 Apr 15; 284(15):819-22. PubMed ID: 5549804
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.
    Liuzzi A, Chiodini PG, Botalla L, Silvestrini F, Müller EE.
    J Clin Endocrinol Metab; 1974 Nov 15; 39(5):871-6. PubMed ID: 4214404
    [No Abstract] [Full Text] [Related]

  • 15. Endocrine effects of naloxone-induced opiate receptor blockade.
    Morley JE, Baranetsky NG, Wingert TD, Carlson HE, Hershman JM, Melmed S, Levin SR, Jamison KR, Weitzman R, Chang RJ, Varner AA.
    J Clin Endocrinol Metab; 1980 Feb 15; 50(2):251-7. PubMed ID: 6243662
    [No Abstract] [Full Text] [Related]

  • 16. [The effects of somatostatin in acromegaly].
    Schaison G, Roger M, Milhaud G.
    Nouv Presse Med; 1976 Mar 06; 5(10):629-32. PubMed ID: 772591
    [Abstract] [Full Text] [Related]

  • 17. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
    Hoyte KM, Martin JB.
    J Clin Endocrinol Metab; 1975 Oct 06; 41(4):656-9. PubMed ID: 809457
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone and somatomedin levels in acromegalics treated with bromocriptine.
    Shalet SM, Price DA, Beardwell CG, Mindel A, MacFarlane IA.
    Horm Res; 1980 Oct 06; 12(3):121-9. PubMed ID: 6768666
    [No Abstract] [Full Text] [Related]

  • 19. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G, Zäh W, Hackenberg K, Hamburger B, Günnewig H, Reinwein D.
    Horm Metab Res; 1976 Jul 06; 8(4):291-5. PubMed ID: 182633
    [Abstract] [Full Text] [Related]

  • 20. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly.
    Lamberts SW, Liuzzi A, Chiodini PG, Verde S, Klijn JG, Birkenhäger JC.
    Eur J Clin Invest; 1982 Apr 06; 12(2):151-5. PubMed ID: 6807686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.